http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#Head http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#assertion http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#provenance http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#pubinfo http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#assertion http://purl.obolibrary.org/obo/DOID_8534 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_8534 http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01233 http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association http://www.w3.org/2000/01/rdf-schema#label the use of metoclopramide tablets is recommended for adults only therapy should not exceed 12 weeks in duration symptomatic gastroesophageal reflux metoclopramide tablets are indicated as short term 4 to 12 weeks therapy for adults with symptomatic documented gastroesophageal reflux who fail to respond to conventional therapy the principal effect of metoclopramide is on symptoms of postprandial and daytime heartburn with less observed effect on nocturnal symptoms if symptoms are confined to particular situations such as following the evening meal use of metoclopramide as single doses prior to the provocative situation should be considered rather than using the drug throughout the day healing of esophageal ulcers and erosions has been endoscopically demonstrated at the end of a 12 week trial using doses of 15 mg q i d as there is no documented correlation between symptoms and healing of esophageal lesions patients with documented lesions should be monitored endoscopically diabetic gastroparesis diabetic gastric stasis metoclopramide tablets are indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis the usual manifestations of delayed gastric emptying e g nausea vomiting heartburn persistent fullness after meals and anorexia appear to respond to metoclopramide within different time intervals significant relief of nausea occurs early and continues to improve over a three week period relief of vomiting and anorexia may precede the relief of abdominal fullness by one week or more http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB01233 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#provenance http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#pubinfo http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#sig http://purl.org/nanopub/x/hasSignature MXH/9BKoDct3ClrvzS230ZBzsVB85LDJ81fqo8Fe3VjAnMQSMKpMKty/quDaJQ4AyaMq/PHGVFywF7qQbPI6sRJx8kkYJnjYoPE9meam3ZObCZyDlj6fHQvXyozueemGbsx/sCabWeg+AOjgSdnOHG24FQ6Mr2j8+9lkQu5q5qc= http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ http://purl.org/dc/terms/created 2021-06-21T10:07:59.502+02:00 http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAZBNExVLjLBcW4cfQrpx-jATs95n-VJ2CkPgZWMqEAOQ https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs